|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 254.55 INR | +0.22% |
|
+1.84% | +22.29% |
| 05-20 | Viyash Scientific Limited, Q4 2026 Earnings Call, May 20, 2026 | |
| 05-19 | Viyash Scientific March-quarter consol net profit 521.1 million rupees | RE |
| Market Cap | 111B 1.18B 1.03B 951M 890M 1.67B 1.68B 11.28B 4.37B 54.69B 4.42B 4.33B 190B | P/E 2026 |
45.7x | P/E 2027 * | 29.1x |
|---|---|---|---|---|---|
| Enterprise Value | 114B 1.21B 1.05B 977M 914M 1.71B 1.73B 11.59B 4.49B 56.17B 4.54B 4.44B 195B | EV / Sales 2026 |
2.4x | EV / Sales 2027 * | 2.84x |
| Free-Float |
32.09% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Viyash Scientific Limited
| 1 day | +0.22% | ||
| 1 week | +1.84% | ||
| Current month | -1.74% | ||
| 1 month | +0.97% | ||
| 3 months | +35.08% | ||
| 6 months | +20.90% | ||
| Current year | +22.29% |
| 1 week | 242.55 |  | 259.9 |
| 1 month | 241.45 | | 277.05 |
| Current year | 178.4 | | 277.05 |
| 1 year | 166.2 | | 277.05 |
| 3 years | 80.05 | | 277.05 |
| 5 years | 61.8 | | 336.4 |
| 10 years | 42.45 | | 336.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 2025-12-15 | |
Ramakant Singani
DFI | Director of Finance/CFO | - | 2025-12-31 |
| Chief Tech/Sci/R&D Officer | - | 2026-02-04 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 78 | - | |
| Director/Board Member | 66 | 2020-08-24 | |
| Director/Board Member | 57 | 2022-04-10 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | +1.84% | +36.09% | +212.25% | 1.18B | |
| -1.21% | -3.04% | +44.03% | +143.07% | 980B | |
| -2.48% | -5.18% | +52.47% | +39.15% | 550B | |
| -2.14% | -4.94% | +16.83% | +57.08% | 382B | |
| +0.25% | -3.09% | +23.33% | +16.04% | 316B | |
| +0.61% | -1.69% | +27.35% | +13.73% | 272B | |
| +0.22% | -3.10% | +24.67% | +30.49% | 268B | |
| +4.59% | +1.98% | -38.43% | -46.26% | 199B | |
| -1.19% | -4.95% | +16.68% | +47.69% | 182B | |
| -1.35% | -1.46% | +14.06% | +59.26% | 154B | |
| Average | -0.25% | -2.53% | +21.71% | +57.25% | 330.35B | |
| Weighted average by Cap. | -0.78% | -3.67% | +29.49% | +63.36% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 33.72B 357M 312M 289M 270M 507M 510M 3.42B 1.33B 16.6B 1.34B 1.31B 57.63B | 39.17B 415M 362M 335M 314M 588M 592M 3.98B 1.54B 19.28B 1.56B 1.52B 66.94B |
| Net income | 2.18B 23.1M 20.14M 18.66M 17.46M 32.75M 32.95M 221M 85.78M 1.07B 86.72M 84.86M 3.73B | 3.78B 40.11M 34.97M 32.39M 30.32M 56.86M 57.21M 384M 149M 1.86B 151M 147M 6.47B |
| Net Debt | 3.02B 32M 27.9M 25.84M 24.19M 45.36M 45.63M 307M 119M 1.49B 120M 118M 5.16B | - |
Employees
1,244
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-19 | 254.55 ₹ | +0.22% | 82,248 |
| 26-06-18 | 254.00 ₹ | +3.95% | 173,761 |
| 26-06-17 | 244.35 ₹ | -1.15% | 90,890 |
| 26-06-16 | 247.20 ₹ | -1.04% | 63,501 |
| 26-06-15 | 249.80 ₹ | -0.06% | 72,559 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
254.55INR
Average target price
300.00INR
Spread / Average Target
+17.86%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIYASH Stock
Select your edition
All financial news and data tailored to specific country editions
